1)Ganatra AM and Loughlin KR:The management of malignant ureteral obstruction treated with ureteral stents. J Urol 174:2125-2128, 2005
2)Shimada K, Kakizaki H, Kubota M, et al:Standard method for diagnosis dilatation of the renal pelvis and ureter discovered in the fetus, neonate or infant. Int J Urol 11:129-132, 2004
3)小山善之,斉藤達雄:日本癌治療学会固形がん化学療法効果判定基準:J Jpn Soc Cancer Ther 21:929-942,1986
4)Wong LM, Cleeve LK, Milner AD, et al:Malignant ureteral obstruction:outcomes after intervention:have things changed? J Urol 178:178-183, 2007
5)Kouba E, Wallen EM and Pruthi RS:Management of ureteral obstruction due to advanced malignancy:optimizing therapeutic and palliative outcomes. J Urol 180:444-450, 2008
6)Chung SY, Stein RJ, Landsittel D, et al:15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 172:592-595, 2004
7)Ku JH, Lee SW, Jeon HG, et al:Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies:are there differences? Urology 64:895-899, 2004
8)Vaglio A, Salvarani C and Buzio C:Retroperitoneal fibrosis. Lancet 367:241-251, 2006